Tobramycin (0.3%) + Dexamethasone (0.1%) is an ophthalmic formulation that combines the potent antibacterial properties of an aminoglycoside antibiotic with the anti‑inflammatory effects of a corticosteroid, offering a dual therapeutic benefit for managing complex eye conditions. Tobramycin works by inhibiting bacterial protein synthesis, effectively targeting a wide range of Gram‑negative and some Gram‑positive organisms responsible for ocular infections such as conjunctivitis, blepharitis, and keratitis. Dexamethasone complements this action by suppressing the inflammatory response, reducing swelling, redness, and irritation that often accompany infections or post‑surgical recovery. The integration of these two agents in a single preparation simplifies treatment regimens, ensuring both infection control and symptomatic relief, while enhancing patient compliance. Clinically, this combination is particularly valuable in scenarios where inflammation and bacterial risk coexist, such as after ocular surgery or in severe inflammatory eye conditions with secondary infection risk. The topical formulation ensures direct delivery to ocular tissues, maximizing therapeutic effectiveness while minimizing systemic exposure. Overall, Tobramycin with Dexamethasone eye drops represent a comprehensive solution in ophthalmic care, uniting antimicrobial protection with anti‑inflammatory support to promote healing, safeguard vision, and restore ocular comfort efficiently.